INSMED Inc (INSM)
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
Address
700 US HIGHWAY 202/206
BRIDGEWATER, NJ 08807
Founded
1988
Number of Employees
912
Website
http://www.insmed.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)